SCHEMBL2762349

SCHEMBL2762349

O=C(O)Nc1ccc(Cc2ccc(NC(=O)O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.62
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ LMNA P02545 2/20 0.57
▸ SAE1 Q9UBE0 3/20 0.53
▸ UBA2 Q9UBT2 3/20 0.53
▸ TSHR P16473 1/20 0.53
▸ SLC1A3 P43003 1/20 0.50
▸ SLC1A2 P43004 1/20 0.50
▸ SLC1A1 P43005 1/20 0.50
▸ CCNC P24863 1/20 0.47
▸ CDK8 P49336 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ LTA4H P09960 1/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ SRC P12931 1/20 0.46
▸ NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773254 0.94 SLC1A3 (0.58) POLBMEN1KMT2ALMNASAE1
SCHEMBL28945385 0.90 ALDH1A1 (0.53) POLBMEN1KMT2ALMNANPC1
SCHEMBL4683087 0.90 MAPT (0.55) POLBMEN1KMT2ALMNASAE1
Phenol SCHEMBL663964 0.88 MAOA (0.53) POLBMEN1KMT2ALMNASAE1
SCHEMBL15278098 0.88 POLB (0.51) POLBMEN1KMT2ALMNASAE1
SCHEMBL12604863 0.87 POLB (0.50) POLBMEN1KMT2ALMNASAE1
SCHEMBL18183585 0.87 SMN1; SMN2 (0.56) POLBMEN1KMT2ALMNASAE1
SCHEMBL29135460 0.87 PLA2G10 (0.65) POLBMEN1KMT2ALMNASLC1A3
SCHEMBL18183584 0.87 POLB (0.50) POLBMEN1KMT2ALMNASAE1
SCHEMBL29092627 0.86 POLB (0.50) POLBNPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1420013-B1 Process for hydrogenating aromatic urethanes in the presence of a supported ruthenium catalyst EVONIK DEGUSSA GMBH (DE) 2008-04-02 — — EP claimed
EP-1420012-B1 Process for the preparation of aliphatic isocyanates from aromatic isocyanates DEGUSSA (DE) 2006-11-02 — — EP claimed
EP-1362901-B1 Thermoset adhesive films NAT STARCH CHEM INVEST (US) 2006-03-15 — — EP claimed
US-6924385-B2 Method for synthesis of aliphatic isocyanates from aromatic isocyanates DEGUSSA AG (DE) 2005-08-02 — — US claimed
US-6809215-B2 SUCH AS CONVERSION OF DIBUTYL 4,4'-METHYLENEDICARBANILATE TO DIBUTYL 4,4'-METHYLENEDICYCLOHEXYLCARBAMATE WITH LOW TRANS-TRANS ISOMER CONTENT DEGUSSA AG (DE) 2004-10-26 — — US claimed
US-20040097752-A1 Method for synthesis of aliphatic isocyanates from aromatic isocyanates DEGUSSA AG (DE) 2004-05-20 — — US claimed
US-20040097661-A1 Method for hydrogenation of aromatic urethanes in the presence of a supported rutheniun catalyst DEGUSSA AG (DE) 2004-05-20 — — US claimed
EP-1420013-A1 Process for hydrogenating aromatic urethanes in the presence of a supported ruthenium catalyst Degussa AG (DE) 2004-05-19 — — EP claimed
EP-1420012-A1 Process for the preparation of aliphatic isocyanates from aromatic isocyanates Degussa AG (DE) 2004-05-19 — — EP claimed
WO-2003031492-A1 THERMALLY REWORKABLE EPOXY RESINS AND COMPOSITIONS BASED THEREO N HENKEL CORPORATION (US) 2003-04-17 — — WO claimed
EP-0014482-B1 PREPARATION OF DIPHENYLMETHANE DICARBAMATES AND POLYMETHYLENE POLYPHENYL CARBAMATES WITH LEWIS ACID CATALYSTS INTERCALATED IN GRAPHITE ATLANTIC RICHFIELD COMPANY (US) 1981-11-25 — — EP claimed
JP-3083959-A — — None — — JP disclosed
JP-55081850-A — — None — — JP disclosed
EP-3412730-B1 AQUEOUS DISPERSION, PRODUCTION METHOD THEREFOR, AND IMAGE FORMATION METHOD FUJIFILM CORP (JP) 2025-03-19 — — EP disclosed
EP-4347727-A1 PRINTING INK Fujifilm Speciality Ink Systems Limited (GB) 2024-04-10 — — EP disclosed
US-4141883-A Stabilization of synthetic polymers by penta-or-hexa-substituted 4-piperidinol derivatives SANKYO COMPANY, LIMITED (JP) 1979-02-27 — — US disclosed
US-4132702-A Phenol esters and amides and polymers stabilized therewith CIBA-GEIGY CORPORATION (US) 1979-01-02 — — US disclosed
US-4075165-A 2,2,6,6-TETRA-SUBSTITUTED-4-PIPERIDINOL CIBA-GEIGY CORPORATION (US) 1978-02-21 — — US disclosed
US-4069240-A GROUP 8 METAL CATALYST UNIROYAL, INC. (US) 1978-01-17 — — US disclosed
US-3968092-A Use of aromatic furfuryl polycarbamates as chloroprene polymer vulcanization accelerators E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097752-A1 Method for synthesis of aliphatic isocyanates from aromatic isocyanates DBI, ALKBH3, ECI1 POLB 1601/4885MEN1 1069/4885KMT2A 1102/4885
US-20040097661-A1 Method for hydrogenation of aromatic urethanes in the presence of a supported rutheniun catalyst HRH4, BET1, HRH3 POLB 985/4885MEN1 822/4885KMT2A 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback